Experimental Antibody-Drug Conjugate Shrinks Brain Metastasis in Rare Salivary Gland Cancer
A case report describes a durable 54.5 percent shrinkage of a dural-based brain metastasis in a patient with HER2-negative salivary ...
A case report describes a durable 54.5 percent shrinkage of a dural-based brain metastasis in a patient with HER2-negative salivary ...
A new study shows that inhibiting the kinase PTK6 with the drug tilfrinib suppresses the proliferation and migration of ovarian ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine